Mondelez International Inc (MDLZ) Raised to "Buy" at TheStreet

Adjust Comment Print

Mondelez also has an attractive portfolio of iconic brands, commanding presence in impulsive categories and fast-growing emerging markets. While some analysts have a High Price target for the stock of $54 and a Low Price Target of $45.

Let's take a look at analyst target price estimates on the stock. Berenberg Initiates Coverage On the company's stock to Buy on 1/05/17 with no specific Price Target. According to these analysts, the Low Revenue Estimate for Mondelez International, Inc.is 6.31 Billion and the High Revenue Estimate is 6.51 Billion. Five analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. Analysts have a mean recommendation of 2.30 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). (MDLZ) in which Deutsche Bank Initiates Coverage On Mondelez International, Inc.

The counter witnessed a trading volume of 6.25 million shares versus an average volume of 8.02 million shares during last trading session. Mondelez International Inc has a 52-week low of $40.50 and a 52-week high of $46.40. The stock is now trading with a distance of 20-Day Simple Moving Average (SMA20) of 0.67%.

TRADEMARK VIOLATION NOTICE: "11,840 Shares in Mondelez International Inc (MDLZ) Acquired by Dodge & Cox" was first posted by BBNS and is the property of of BBNS. The company reported $0.47 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.49 by $0.02. The company had Year Ago Sales of 6.46 Billion. During the same period in the prior year, the company posted $0.46 EPS.

While looking at the Stock's Performance, Mondelez International, Inc. now shows a Weekly Performance of 1.72%, where Monthly Performance is 4.36%, Quarterly performance is 1.73%, 6 Months performance is 8.75% and yearly performance percentage is 9.55%.

Does $12.5 justifies Akebia Therapeutics, Inc. (AKBA) shares?
Vadadustat is now in late-stage clinical trials for the treatment of anemia in patients with chronic kidney disease. Dimensional Fund Advisors LP raised its stake in shares of Akebia Therapeutics by 3.9% in the fourth quarter.

Mondelez International, Inc.'s P/E stands at 43.06, while the P/S is at 2.7 and earnings per share this year of -76.20%.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 13th. Stockholders of record on Friday, March 31st were given a $0.19 dividend. The ex-dividend date of this dividend was Wednesday, March 29th. This represents a $0.76 annualized dividend and a dividend yield of 1.67%.

Currently, the market capitalization of Mondelez International, Inc. The Relative Volume value measured for Mondelez International, Inc. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & global copyright & trademark laws. Also, EVP Maurizio Brusadelli sold 1,600 shares of the stock in a transaction that occurred on Wednesday, February 22nd. The shares were sold at an average price of $44.80, for a total transaction of $71,680.00. Following the completion of the transaction, the executive vice president now directly owns 59,031 shares in the company, valued at approximately $2,469,857.04. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The shares were purchased at an average cost of $44.95 per share, for a total transaction of $89,900.00. The disclosure for this purchase can be found here.

Two other important profitability ratios for investors to know are both returns-based ratios that measure a company's ability to create wealth for shareholders. First Command Bank purchased a new stake in Mondelez International during the fourth quarter worth $109,000. The Timber Hill Llc holds 104,159 shares with $4.62M value, up from 39,614 last quarter. Timber Hill Llc acquired 64,545 shares as Mondelez International Inc (MDLZ)'s stock rose 1.26%. Suntrust Banks Inc. boosted its position in shares of Mondelez International by 1.6% in the third quarter. (NYSE:BANC) last session's volume of 2.63 million shares was higher than its average volume of 1.6 million shares. Bank & Trust Of America Corporation De has 0.34% invested in Mondelez International Inc (NASDAQ:MDLZ) for 35.00M shares. Adirondack Trust Co. now owns 2,330 shares of the company's stock valued at $100,000 after buying an additional 45 shares during the last quarter. Enterprise Financial Services Corp now owns 4,152 shares of the company's stock valued at $182,000 after buying an additional 48 shares during the last quarter.

Comments